Summary:
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Prevention of Migraine in Episodic Migraine Patients
Qualified Participants Must:
• 18-65 years old
• History of migraine headache disorder
• 6-14 migraine days a month in each of the 3 months prior
Qualified Participants May Receive:
- Compensation for time and travel.
- Study-related care at no cost.